Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 2
2002 1
2004 2
2005 2
2006 1
2007 1
2008 2
2009 1
2010 3
2011 3
2012 8
2013 2
2014 7
2015 3
2016 2
2017 4
2018 2
2019 2
2020 3
2021 5
2022 4
2023 7
2024 4
2025 6
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
The structural basis for LRRK2's activation and autoinhibition.
Suarez AV, Hatch KS, Bodrug T, Gai W, Surridge KJ, Moussikhina E, Nguyen KH, Sanz-Murillo M, Callahan R, Xiong E, Ramos D, Zhu L, Dederer V, Mathea S, Iwasa J, Knapp S, Shokat KM, Reck-Peterson SL, Leschziner AE. Suarez AV, et al. Among authors: reck peterson sl. bioRxiv [Preprint]. 2026 Jun 3:2026.05.31.729085. doi: 10.64898/2026.05.31.729085. bioRxiv. 2026. PMID: 42282830 Free PMC article. Preprint.
The molecular architecture of tunneling nanotubes.
Karasmanis EP, Chen S, Shaikh F, Abrisch RG, Flaherty A, Badell-Grau RA, Riggi M, Nguyen LV, Hutchings J, Basiashvili T, Lattal N, Cherqui S, Villa E, Reck-Peterson SL. Karasmanis EP, et al. Among authors: reck peterson sl. bioRxiv [Preprint]. 2026 May 28:2026.05.27.728322. doi: 10.64898/2026.05.27.728322. bioRxiv. 2026. PMID: 42244744 Free PMC article. Preprint.
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2.
Raig ND, Surridge KJ, Sanz-Murillo M, Dederer V, Krämer A, Schwalm MP, Lattal NM, Elson L, Chatterjee D, Mathea S, Hanke T, Leschziner AE, Reck-Peterson SL, Knapp S. Raig ND, et al. Among authors: reck peterson sl. Sci Adv. 2025 Jun 6;11(23):eadt2050. doi: 10.1126/sciadv.adt2050. Epub 2025 Jun 4. Sci Adv. 2025. PMID: 40465731 Free PMC article.
Multiple steps of dynein activation by Lis1 visualized by cryo-EM.
Kendrick AA, Nguyen KHV, Ma W, Karasmanis EP, Amaro RE, Reck-Peterson SL, Leschziner AE. Kendrick AA, et al. Among authors: reck peterson sl. Nat Struct Mol Biol. 2025 Aug;32(8):1434-1444. doi: 10.1038/s41594-025-01558-w. Epub 2025 May 23. Nat Struct Mol Biol. 2025. PMID: 40410592 Free PMC article.
Cell biology meets climate resilience - a call to action.
Bettencourt-Dias M, Gladfelter A, Dey G, Reck-Peterson SL. Bettencourt-Dias M, et al. Among authors: reck peterson sl. J Cell Sci. 2025 Mar 15;138(6):jcs263987. doi: 10.1242/jcs.263987. Epub 2025 Mar 19. J Cell Sci. 2025. PMID: 40105116 No abstract available.
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2.
Raig ND, Surridge KJ, Sanz-Murillo M, Dederer V, Krämer A, Schwalm MP, Elson L, Chatterjee D, Mathea S, Hanke T, Leschziner AE, Reck-Peterson SL, Knapp S. Raig ND, et al. Among authors: reck peterson sl. bioRxiv [Preprint]. 2025 Feb 13:2024.09.17.613365. doi: 10.1101/2024.09.17.613365. bioRxiv. 2025. Update in: Sci Adv. 2025 Jun 6;11(23):eadt2050. doi: 10.1126/sciadv.adt2050. PMID: 39554022 Free PMC article. Updated. Preprint.
81 results